Skip to content
★ Sign in to follow
파마

파마리서치바이오 Stock: price and insider trades · South Korea

No insider purchase over the last 90 days. The latest, by 파마리서치, was filed 19 Sept 2023.

파마리서치바이오: what insiders have been doing

파마리서치바이오 is a Health Care company. Its directors and officers file their transactions with DART (FSS). The last twelve months, up to 31 October 2026, brought 2 filings signed by 2 insiders.

There is no open-market purchase to report; the filings show 1 sale by 1 insider. The amount is not disclosed for 1 filing.

Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.

For context, the typical company on the same exchange (median of 2,655 companies) published 7 filings over the same period, against 2 filings here. Our records for 파마리서치바이오 go back to 2021, with 3 purchases and 7 sales on the open market in total.

Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and UCB. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.

Insider Decl.
12
Thresholds
n/a
Buy Volume
€9M
3 ops. · all time
Sell Volume
€12M
7 ops. · all time

Who traded when

BuySale
신한캐피탈1 sale

Since the insiders bought

  • Filed 19 Sept 2023 · 1148 days ago · €6.3M
    +66.2%
    Entry 21,000.00 · Close at T+365 34,900.00
  • Filed 28 Mar 2023 · 1323 days ago · €32k
    +48.5%
    Entry 20,500.00 · Close at T+365 30,450.00

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Financial data

· cache

Last declaration on 12 March 2026
Declarations14 total
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ▼
    Related company / holdingExecutives
    €2.1Mest.0DART
    106,225 sharesKRXDART:20260304001653
  • ▲
    Executives
    9B KRW10DART
    426,440 shares@ ₩21,105.00100.0% of flowShareKRXDART:20230919000307
    Canonical exit: 24 Aug 2023 (T+90)
  • ▼
    Executives
    €217kest.0DART
    14,600 sharesShareKRXDART:20230919000317
  • ▼
    Related company / holdingExecutives
    €1.6Mest.0DART
    106,225 sharesKRXDART:20230919000303
  • ▲
    Executives
    45M KRW10DART
    2,002 shares@ ₩22,260.9835100.0% of flowShareKRXDART:20230328000313
    Canonical exit: 22 Jun 2023 (T+90)
  • ▲
    Executives(filed)
    €2.5Mest.0DART
    100,000 sharesKRXDART:20220331001646
    Canonical exit: 29 Jun 2022 (T+90)
  • ●
    Executives
    Executives(filed)
    0DART
  • ▼
    Related company / holdingExecutives(filed)
    €2.4Mest.0DART
    106,225 sharesKRXDART:20211129000378
  • ▼
    Related company / holdingExecutives(filed)
    €1.9Mest.0DART
    106,225 sharesKRXDART:20210615000164
  • ▼
    Related company / holdingExecutives(filed)
    €1.9Mest.0DART
    106,225 sharesKRXDART:20210608000017
  • ▼
    Related company / holdingExecutives(filed)
    €1.8Mest.0DART
    106,225 sharesKRXDART:20210603000213

14 of 14 declarations

About 파마리서치바이오

파마리서치바이오 operates in the health and pharmaceutical sector, listed on the XKRX market. The company focuses on the research and development of biopharmaceutical solutions.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations